Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...
Donating blood at Versiti's downtown Milwaukee center is a straightforward process that can help save lives, with donations ...
A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer ...
Money Talks News on MSN
A simple blood test claims to detect 50 cancers but isn't FDA-approved yet
A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...
Recent research suggests that more people should be screened for a protein called apoB. A growing number of doctors agree.
Elche General Hospital introduces virtual reality glasses to reduce patient anxiety during blood draws and improve overall ...
A child's years-long medical mystery was finally solved.
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.
In 1972, a pregnant woman’s blood sample was collected for routine tests. It was here that something unusual was discovered: her blood lacked a surface antigen, known as the AnWj antigen, which was ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
A San Diego company has earned FDA clearance for a device that could make blood testing easier. Truvian Health’s device, TruVerus, uses a small amount of blood to return routine tests quickly. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results